Literature DB >> 25609517

Response.

James Douketis1, John Eikelboom1, Aaron Liew1, Alan David Bell2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25609517      PMCID: PMC4301758     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

Review 1.  Approach to the new oral anticoagulants in family practice: part 1: comparing the options.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

2.  Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

3.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

Authors:  Atul Verma; John A Cairns; L Brent Mitchell; Laurent Macle; Ian G Stiell; David Gladstone; Michael Sean McMurtry; Stuart Connolly; Jafna L Cox; Paul Dorian; Noah Ivers; Kori Leblanc; Stanley Nattel; Jeff S Healey
Journal:  Can J Cardiol       Date:  2014-08-13       Impact factor: 5.223

5.  Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.

Authors:  A Liew; M O'Donnell; J Douketis
Journal:  J Thromb Haemost       Date:  2014-07-25       Impact factor: 5.824

6.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

7.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.